Full Text
Quality of evidence supporting inclusion of Pharmacogenomic biomarkers in product labels of fda approved Oncology Therapies

Abstract

Authors

RK Jha J Gupta A Kapoor D Mazumder

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×